The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Primary brain tumours in adults
Ricard, D., Idbaih, A., Ducray, F., Lahutte, M., Hoang-Xuan, K., & Delattre, J.-Y. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61346-9 · Cited by 1,201
Paclitaxel and its formulations
Singla, A. K., Garg, A., & Aggarwal, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00986-3 · Cited by 1,100
Epidemiology of primary brain tumors: Current concepts and review of the literature
Wrensch, M., Minn, Y., Chew, T., Bondy, M., & Berger, M. S. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.4.278 · Cited by 837
Primary brain tumours in adults
Behin, A., Hoang-Xuan, K., Carpentier, A. F., & Delattre, J.-Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12328-8 · Cited by 754
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 715
Diffuse glioma growth: a guerilla war
Claes, A., Idema, A. J., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0293-7 · Cited by 636
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
Christian, S., Pilch, J., Akerman, M. E., Porkka, K., Laakkonen, P., & Ruoslahti, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304132 · Cited by 497
Liu, D., Mori, A., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90136-a · Cited by 463
Hadjipanayis, C. G., Machaidze, R., Kaluzova, M., Wang, L., Schuette, A. J., Chen, H., Wu, X., & Mao, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1022 · Cited by 419
Self-citationZhang, Z., & Feng, S.-S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.006 · Cited by 414
Xin, H., Jiang, X., Gu, J., Sha, X., Chen, L., Law, K., Chen, Y., Wang, X., Jiang, Y., & Fang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.044 · Cited by 384
Self-citationReyes-Reyes, E. M., Teng, Y., & Bates, P. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0920 · Cited by 383
Régina, A., Demeule, M., Ché, C., Lavallée, I., Poirier, J., Gabathuler, R., Béliveau, R., & Castaigne, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.260 · Cited by 368
Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y., & Lu, W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.020 · Cited by 366
Kelland, L. R. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.028 · Cited by 352
Electrospun Micro- and Nanofibers for Sustained Delivery of Paclitaxel to Treat C6 Glioma in Vitro
Xie, J., & Wang, C.-H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9036-z · Cited by 339
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.011 · Cited by 335
PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors
He, H., Li, Y., Jia, X.-R., Du, J., Ying, X., Lu, W.-L., Lou, J.-N., & Wei, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.002 · Cited by 303
Petri, B., Bootz, A., Khalansky, A., Hekmatara, T., Müller, R., Uhl, R., Kreuter, J., & Gelperina, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 298
Gao, X., Tao, W., Lu, W., Zhang, Q., Zhang, Y., Jiang, X., & Fu, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.038 · Cited by 295
Self-citationHwang, D. W., Ko, H. Y., Lee, J. H., Kang, H., Ryu, S. H., Song, I. C., Lee, D. S., & Kim, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069880 · Cited by 293
CHEN, D.-B., YANG, T.-Z., LU, W.-L., & ZHANG, Q. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.1444 · Cited by 243
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
Soundararajan, S., Wang, L., Sridharan, V., Chen, W., Courtenay-Luck, N., Jones, D., Spicer, E. K., & Fernandes, D. J. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055947 · Cited by 240
Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells
Legrand, D., Vigié, K., Said, E. A., Elass, E., Masson, M., Slomianny, M., Carpentier, M., Briand, J., Mazurier, J., & Hovanessian, A. G. (2004) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03929.x · Cited by 227
Hovanessian, A. G., Soundaramourty, C., Khoury, D. E., Nondier, I., Svab, J., & Krust, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015787 · Cited by 217
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
Panagi, Z., Beletsi, A., Evangelatos, G., Livaniou, E., Ithakissios, D. S., & Avgoustakis, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00676-7 · Cited by 215
Chitosan–alginate 3D scaffolds as a mimic of the glioma tumor microenvironment
Kievit, F. M., Florczyk, S. J., Leung, M. C., Veiseh, O., Park, J. O., Disis, M. L., & Zhang, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.062 · Cited by 209
Yu, D.-H., Lu, Q., Xie, J., Fang, C., & Chen, H.-Z. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.047 · Cited by 175
Self-citationNikanjam, M., Gibbs, A. R., Hunt, C. A., Budinger, T. F., & Forte, T. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.007 · Cited by 165
Xin, H., Chen, L., Gu, J., Ren, X., wei, Z., Luo, J., Chen, Y., Jiang, X., Sha, X., & Fang, X. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.005 · Cited by 147
Self-citationIn vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery
Xu, Z., Gu, W., Huang, J. C., Sui, H., Zhou, Z., Yang, Y., Zhou, Y., & Li, Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.009 · Cited by 147
Use of nude mouse xenograft models in prostate cancer research
van Weerden, W. M., & Romijn, J. C. (2000) · The Prostate · Cited by 141
Liang, B., He, M., Chan, C.-Y., Chen, Y., Li, X., Li, Y., Zheng, D., Lin, M. C. M., Kung, H., Shuai, X., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.011 · Cited by 116
Chemotherapy wafers for high grade glioma
Hart, M. G., Garside, R., Rogers, G., Somerville, M., Stein, K., & Grant, R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007294.pub2 · Cited by 102
Zhang, X., Chen, J., Zheng, Y., Gao, X., Kang, Y., Liu, J.-C., Cheng, M., Sun, H., & Xu, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4721 · Cited by 98
Self-citationFogal, V., Sugahara, K. N., Ruoslahti, E. I., & Christian, S. (2009) · Angiogenesis · doi:10.1007/s10456-009-9137-5 · Cited by 92
Aptamer Applications for Targeted Cancer Therapy
Barbas, A. S., Mi, J., Clary, B. M., & White, R. R. (2010) · Future Oncology · doi:10.2217/fon.10.67 · Cited by 88
Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles
Gao, X., Wang, T., Wu, B., Chen, J., Chen, J.-Y., Yue, Y., Dai, N., Chen, H., & Jiang, X. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.077 · Cited by 85
Self-citationThe therapeutic efficacy of conjugated linoleic acid – Paclitaxel on glioma in the rat
Ke, X., Zhao, B., Zhao, X., Wang, Y., Huang, Y. M., Chen, X.-M., Zhao, B., Zhao, S., Zhang, X. K., & Zhang, Q. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.079 · Cited by 78
Kim, S., Gaber, M. W., Zawaski, J. A., Zhang, F., Richardson, M. M., Zhang, X. A., & Yang, Y. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.010 · Cited by 63
Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
Hájek, R., Vorlíček, J., & Slavík, M. (1996) · PubMed · Cited by 40
Gao, J., Jia, W.-D., Li, J.-S., Wang, W., Xu, G.-L., Ma, J., Ge, Y.-S., Yu, J., Ren, W.-H., Liu, W. B., et al. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800423 · Cited by 31
Beljebbar, A., Dukic, S., Amharref, N., Bellefqih, S., & Manfait, M. (2009) · Analytical Chemistry · doi:10.1021/ac901464v · Cited by 28
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Metadata
- Authors
- Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 32
- Issue
- 31
- Pages
- 8010-8020
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2055494875
- Cited by
- 566
- References
- 51
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.